Related Experiment Video
Updated: Jun 27, 2025

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Pulmonary Arterial Hypertension with Features of Venous Involvement: A Detective's Task
Daniel Inácio Cazeiro1, Rui Plácido1, Miguel Azeredo Raposo1
1Departamento de Coração e Vasos - Centro Hospitalar Universitário Lisboa Norte - Faculdade de Medicina de Lisboa - Universidade de Lisboa, Lisboa - Portugal.
Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension. Early clinical suspicion and prompt lung transplant referral are crucial for successful outcomes in patients with this severe condition.
Area of Science:
- Cardiology
- Pulmonology
- Pathology
Background:
- Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis are rare, severe forms of pulmonary arterial hypertension (PAH).
- These conditions involve fibroproliferation in small pulmonary veins/capillaries, leading to pre-capillary pulmonary hypertension.
- Diagnosis is challenging due to non-specific symptoms and risks associated with lung biopsy.
Observation:
- Clinical presentation of PVOD is often unspecific, mimicking other PAH etiologies.
- Key indicators for presumptive diagnosis include smoking history, chemotherapy or solvent exposure, low diffusing capacity for carbon monoxide (DLCO), and exercise-induced desaturation.
- Imaging may reveal ground glass opacities, septal lines, and lymphadenopathies, suggesting venous congestion without left heart disease.
Findings:
- Histological analysis confirms PVOD, but is often avoided due to complication risks.
- A combination of clinical and imaging findings can support a presumptive diagnosis.
- Lung transplantation is the only definitive treatment for PVOD.
Implications:
- Early diagnosis and referral for lung transplantation are critical due to the rapid progression and poor prognosis of PVOD.
- Prompt management, as illustrated by a successful case, can significantly improve patient outcomes.
- Increased clinical suspicion and awareness of diagnostic clues are vital for timely intervention.
More Related Videos
07:29The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...